Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M389Revenue (TTM) $M104Net Margin (%)-160.0Altman Z-Score-12.8
Enterprise Value $M562EPS (TTM) $-1.4Operating Margin %-121.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score5.1Pre-tax Margin (%)-160.8Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.9Cash flow > EarningsY
Price/Sales3.65-y EBITDA Growth Rate %-32.0Current Ratio1.0Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-104.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M130ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with MACK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
MACKJoel Greenblatt 2015-06-30 Sold Out $10.76 - $13.67
$ 3.00-75%Sold Out0
MACKJoel Greenblatt 2015-03-31 Buy $8.78 - $12.48
$ 3.00-72%New holding13,433
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MACK is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

MACK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Schoeberl Birgit M.Head of Discovery 2016-07-25Sell50,000$5.5-45.45view
PORTER MICHAEL EDirector 2016-03-17Buy5,000$7.2-58.33view
PORTER MICHAEL EDirector 2016-03-15Buy5,000$7.65-60.78view
PORTER MICHAEL EDirector 2016-03-08Buy10,000$7.09-57.69view
PORTER MICHAEL EDirector 2016-03-03Buy15,000$6.39-53.05view
PORTER MICHAEL EDirector 2016-03-01Buy20,000$6.11-50.9view
Lee Vivian SDirector 2016-02-29Buy35,000$5.5-45.45view
McClements William M.Head of Corporate Operations 2016-02-29Buy2,000$5.72-47.55view
Stewart Edward J.Head of Commercial 2016-01-05Sell4,000$8-62.5view
Stewart Edward J.Head of Commercial 2015-12-01Sell5,000$9.33-67.85view

Quarterly/Annual Reports about MACK:

    News about MACK:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Starbucks Corp, KD Supply Holdings Inc, Capital One Financial Corp, Merr Dec 14 2014 

    More From Other Websites
    MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Jan 20 2017
    Merrimack Names Richard Peters, M.D., Ph.D., as President and CEO Jan 18 2017
    Merrimack (MACK) Goes Uphill: Is a Turnaround Likely? Jan 17 2017
    DryShips, Alcobra Sink into Tuesday’s 52-Week Low Club Jan 17 2017
    Merrimack Pharmaceuticals Prospects for the New MACK and Review Jan 17 2017
    Latest Reports on Diffusion and Merrimack as Drug Stocks are Hit by President Trump's Comments Jan 12 2017
    Macy’s, Teva Join Wednesday’s 52-Week Low Club Jan 11 2017
    Is the Options Market Predicting a Spike in Merrimack (MACK) Stock? Jan 11 2017
    DryShips, Merrimack Pharma Stuck in Tuesday’s 52-Week Low Club Jan 10 2017
    Merrimack Pharmaceuticals Inc (MACK) Cancer Drugs Sold To Ipsen Jan 10 2017
    Company News for January 10, 2017 Jan 10 2017
    Merrimack (MACK) Sells Onivyde Rights to Ipsen for $1B Jan 09 2017
    So the Nasdaq Is At a Historical High but the Dow Is Going Opposite Direction Jan 09 2017
    Merrimack Pharma to Sell Cancer Drugs for $1B Jan 09 2017
    Merrimack Sells Pancreatic Cancer Drug to Ipsen for $1 Billion Jan 09 2017
    Biotech Stocks Surge Monday Amid Flurry of Deal Activity Jan 09 2017
    Monday’s 4 Biggest Biopharma Movers Jan 09 2017
    Merrimack Pharmaceuticals' stock soars on heavy volume after drug sale deal Jan 09 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)